Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
3
×
boston
boston blog main
clinical trials
deals
generic drugs
investing
medical device
national blog main
renaissance capital
startups
10x genomics
480 biomedical
arsenal medical
bioinnovation capital
biolabs
biotech ipos
bob langer
boston top stories
chemotherapy
chronic rhinosinusitis
covid-19
daraprim
desmoid tumors
dihydroergotamine
drug delivery
drug pricing
drugs
epipen
epipens
exome
fda
gene therapy
genzyme
george whitesides
inflammation
insulin
ipo
johannes fruehauf
What
biotech
3
×
public
3
×
ipo
life
markets
way
boost
companies
company
debut
developing
driving
drug
followed
genomics
good
haul
healthcare
history
improved
industry
innovation
innovations
investment
late
led
long
lyra
medical
million
new
nose
noses
outcomes
persistently
pricing
proud
raised
raises
runny
Language
unset
Current search:
biotech
×
public
×
" life sciences "
×
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Drug Pricing: Innovation, Investment, and the Public Good
@xconomy.com
4 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
